Tri Locum Partners LP 13F Holdings
CIK 0001826434 · NEW YORK, NY
As of Sep 30, 2025, Tri Locum Partners LP reported 18 positions worth $435.1M in its SEC Form 13F filing.
Top 18 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | JNJ | Healthcare | 302,831 | $56.2M | 12.91% |
| UNITED THERAPEUTICS CORP | UTHR | Healthcare | 122,187 | $51.2M | 11.77% |
| MERCK & CO INC | MRK | Healthcare | 446,874 | $37.5M | 8.62% |
| AXSOME THERAPEUTICS INC | AXSM | Healthcare | 292,137 | $35.5M | 8.16% |
| ASCENDIS PHARMA A | ASND | Healthcare | 174,829 | $34.8M | 7.99% |
| VERA THERAPEUTICS INC | VERA | Healthcare | 1,190,207 | $34.6M | 7.95% |
| ARGENX SE | ARGX | Healthcare | 43,411 | $32.0M | 7.36% |
| MADRIGAL PHARMACEUTICALS INC | MDGL | Healthcare | 67,706 | $31.1M | 7.14% |
| SOLENO THERAPEUTICS INC | SLNO | Healthcare | 450,585 | $30.5M | 7.00% |
| ABBVIE INC | ABBV | Equity | 89,621 | $20.8M | 4.77% |
| KORRO BIO INC | KRRO | Healthcare | 337,764 |